Prism Medico & Pharmacy has informed that pursuant to the provisions of Regulation 30(2) of the securities and Exchange Board of India (Listing obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors in their meeting held on Monday, 30th December 2019 at 1:00 pm and concluded at 1:30 pm has Considered and approved the resignation of Swati Pandey, Company Secretary and Compliance Officer of the Company with effect from 31st December, 2019.
The above information is a part of company’s filings submitted to BSE.
